Optimizing drug development in oncology by clinical trial simulation: Why and how?

Jocelyn Gal, Gérard Milano, Jean-Marc Ferrero, Esma Saâda-Bouzid, Julien Viotti, Sylvie Chabaud, Paul Gougis, Christophe Le Tourneau, Renaud Schiappa, Agnes Paquet, Emmanuel Chamorey. Optimizing drug development in oncology by clinical trial simulation: Why and how?. Briefings in Bioinformatics, 19(6):1203-1217, 2018. [doi]

Authors

Jocelyn Gal

This author has not been identified. Look up 'Jocelyn Gal' in Google

Gérard Milano

This author has not been identified. Look up 'Gérard Milano' in Google

Jean-Marc Ferrero

This author has not been identified. Look up 'Jean-Marc Ferrero' in Google

Esma Saâda-Bouzid

This author has not been identified. Look up 'Esma Saâda-Bouzid' in Google

Julien Viotti

This author has not been identified. Look up 'Julien Viotti' in Google

Sylvie Chabaud

This author has not been identified. Look up 'Sylvie Chabaud' in Google

Paul Gougis

This author has not been identified. Look up 'Paul Gougis' in Google

Christophe Le Tourneau

This author has not been identified. Look up 'Christophe Le Tourneau' in Google

Renaud Schiappa

This author has not been identified. Look up 'Renaud Schiappa' in Google

Agnes Paquet

This author has not been identified. Look up 'Agnes Paquet' in Google

Emmanuel Chamorey

This author has not been identified. Look up 'Emmanuel Chamorey' in Google